As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Biocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Guardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, co-marketed by...

Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...

Chinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough si...

Zydus Lifesciences' subsidiary partners with Zhuhai Beihai Biotech to market Beizray, a cancer drug, in the US. Zhuhai will handle manufact...

US President Joe Biden will deliver a speech on the American revolutionary vision of cancer treatment and cure on Monday in Boston. His add...

The method was to give another common drug just when the cancer cells begin to morph into a stem-cell like type that can avoid the chemo dr...

The deal values the personalised oncology solution provider at about Rs 200 crore, according to a person with direct knowledge of the trans...

The global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.

Biotech firm Actis Biologics today said that Angiozyme, its biotech molecule targeted at colorectal cancer has entered into the third phase...

The Bangalore-based Mitra Biotech, a biology research firm and spin-off from MIT, US, has received venture capital funding from Accel Partn...

West Bengal will soon house a world-class research facility for cancer.

Biotech major Biocon Ltd on Thursday said it will enter into a partnership with a US-based biotechnology company, Iatrica, to develop drug ...

The tests will initially be only for cancer patients and Mr Saxena’s company, Acton Biotech, plans to cover other diseases later.